NuVue Therapeutics, Inc. [www.nuvuetherapeutics.com] is a medical device, diagnostics, and drug delivery company with an initial focus on accurate diagnosis and targeted treatment of liver, pancreatic, and other hard-to-treat soft-tissue cancers. NuVue’s diagnostic products are designed to give a bright, clear image of biopsy needles in real-time during a procedure, and to accurately mark the site for further imaging and/or biopsies. NuVue’s therapeutic products are designed to avoid the toxic effects of systemic chemotherapy by providing targeted delivery of free and encapsulated drugs and thermal effects directly into the tumor. Using only 1/200 – 1/500 the dose, these products will avoid the side effects of systemic chemotherapy, sparing the patient’s immune system and providing a better quality of life during and after therapy. NuVue’s therapeutics will treat all soft tissue cancers. When combined, these diagnostic and therapeutic products will produce a powerful, integrated system for site-specific treatment of all soft-tissue cancers.